Answers are grounded in this paper and cite their sources.
Lacticaseibacillus paracasei is used in fermented foods and has been investigated for oral-health applications, yet the traits supporting food fermentation do not necessarily predict benefit in dental plaque. This narrative review critically compares food-associated phenotypes with strain-resolved oral experimental and clinical evidence, emphasizing biofilm interactions, acidogenicity, host responses, persistence, and safety. Experimental studies of strains such as ET-22 and L9 report inhibition of selected Streptococcus mutans-associated phenotypes and favorable outcomes in animal models, whereas other observations indicate that L. paracasei–pathogen interactions are not uniformly antagonistic. Human studies, particularly those involving SD1 and selected formulated preparations, report changes in mutans streptococci and some oral-health outcomes, but differ in study populations, formulations, endpoints, and follow-up. Evidence for durable oral colonization, community resilience, and sustained clinical benefit remains limited. We distinguish effects demonstrated in oral systems from mechanisms inferred from gastrointestinal or food models and examine the potential conflict between antimicrobial organic-acid production and prolonged plaque acidification. Rather than introducing a new probiotic category, we propose an evidence-informed, six-domain assessment of pathogen interactions, commensal interactions, local metabolism, biofilm ecology, host responses, and persistence and safety. Strain- and formulation-specific net oral effects, not food-associated traits alone, should guide further development.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: